These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 15135978)

  • 41. Bupropion hydrochloride produces conditioned hyperactivity in rats.
    Wilkinson JL; Bevins RA
    Physiol Behav; 2007 Apr; 90(5):790-6. PubMed ID: 17300819
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Baseline behavior, but not sensitivity to stimulant drugs, differs among spontaneously hypertensive, Wistar-Kyoto, and Sprague-Dawley rat strains.
    Ferguson SA; Paule MG; Cada A; Fogle CM; Gray EP; Berry KJ
    Neurotoxicol Teratol; 2007; 29(5):547-61. PubMed ID: 17689921
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Discriminative stimulus properties of substituted amphetamine derivatives.
    Corrigall WA; Coen KM; Saouda FM; Robertson JM; Lodge BA
    Pharmacol Biochem Behav; 1992 Dec; 43(4):1117-9. PubMed ID: 1475294
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of amphetamine on response inhibition in rats showing high or low response to novelty.
    Bardo MT; Cain ME; Bylica KE
    Pharmacol Biochem Behav; 2006 Sep; 85(1):98-104. PubMed ID: 16904737
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Behavioral effects associated with chronic ketamine or remacemide exposure in rats.
    Wright LK; Pearson EC; Hammond TG; Paule MG
    Neurotoxicol Teratol; 2007; 29(3):348-59. PubMed ID: 17291718
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The psychogenetically selected Roman rat lines differ in the susceptibility to develop amphetamine sensitization.
    Corda MG; Piras G; Lecca D; Fernández-Teruel A; Driscoll P; Giorgi O
    Behav Brain Res; 2005 Feb; 157(1):147-56. PubMed ID: 15617781
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Varied effects of conventional antiepileptics on responding maintained by negative versus positive reinforcement.
    Roberts C; Harvey MT; May ME; Valdovinos MG; Patterson TG; Couppis MH; Kennedy CH
    Physiol Behav; 2008 Feb; 93(3):612-21. PubMed ID: 18061218
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Drug discrimination analysis of pseudoephedrine in rats.
    Tongjaroenbuangam W; Meksuriyen D; Govitrapong P; Kotchabhakdi N; Baldwin BA
    Pharmacol Biochem Behav; 1998 Feb; 59(2):505-10. PubMed ID: 9477001
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The monoamine oxidase inhibitor phenelzine enhances the discriminative stimulus effect of nicotine in rats.
    Wooters TE; Bardo MT
    Behav Pharmacol; 2007 Nov; 18(7):601-8. PubMed ID: 17912044
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The reinforcing and discriminative stimulus properties of para-ethoxy- and para-methoxyamphetamine.
    Corrigall WA; Robertson JM; Coen KM; Lodge BA
    Pharmacol Biochem Behav; 1992 Jan; 41(1):165-9. PubMed ID: 1539067
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Schedule-dependent effects of haloperidol and amphetamine: multiple-schedule task shows within-subject effects.
    Caul WF; Brindle NA
    Pharmacol Biochem Behav; 2001 Jan; 68(1):53-63. PubMed ID: 11274708
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Progress report from the testing program for stimulant and depressant drug (1992).
    Woolverton WL; Nader MA; Winger G; Woods JH; Patrick GA; Harris LS
    NIDA Res Monogr; 1993; 132():579-94. PubMed ID: 8101976
    [No Abstract]   [Full Text] [Related]  

  • 53. ABA chronic dosing of D-amphetamine produces differential drug effects in two variants of a temporal discrimination procedure in pigeons.
    McClure EA; Saulsgiver KA; Wynne CD
    Behav Pharmacol; 2009 Dec; 20(8):705-19. PubMed ID: 19901824
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Toward a behavioral toxicology of paint thinner.
    Colotla VA; Lorenzana-Jiménez M; Rodríguez R
    Neurobehav Toxicol; 1980; 2(1):31-6. PubMed ID: 7442918
    [TBL] [Abstract][Full Text] [Related]  

  • 55. In a low-versus high-dose drug discrimination task, random reinforcement in one drug state alters discriminative control only in that state.
    Rijnders HJ; Järbe TU; Slangen JL
    Behav Pharmacol; 1993 Feb; 4(1):37-45. PubMed ID: 11224169
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evaluation of rate-dependency and internal clock effects of D-amphetamine.
    Orduña V; García A; Bouzas A
    Behav Processes; 2012 Jul; 90(3):428-32. PubMed ID: 22542957
    [TBL] [Abstract][Full Text] [Related]  

  • 57. 1-(2,3-Methylenedioxyphenyl)-2-aminopropane (2,3-MDA): a preliminary investigation.
    Glennon RA; Young R; Soine W
    Gen Pharmacol; 1984; 15(4):361-2. PubMed ID: 6149169
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A comparison of the discriminative stimulus properties of R-2,5-dimethoxy-4-methylamphetamine (R-DOM) and S-amphetamine in the rat.
    Tilson HA; Baker TG; Gylys JA
    Psychopharmacologia; 1975 Nov; 44(3):225-8. PubMed ID: 1208758
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Amphetamine-haloperidol discrimination: effects of chronic drug treatment.
    Haenlein M; Caul WF; Barrett RJ
    Pharmacol Biochem Behav; 1985 Dec; 23(6):949-52. PubMed ID: 4080781
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Temporal parameters of cathinone, amphetamine and cocaine.
    Schechter MD
    Pharmacol Biochem Behav; 1989 Oct; 34(2):289-92. PubMed ID: 2622984
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.